The tumorigenic role of DSPP and its potential regulation of the unfolded protein response and ER stress in oral cancer cells

Gkouveris,Ioannis; Nikitakis,Nikolaos   G.; Aseervatham,Jaya; Ogbureke,Kalu   U.E.

doi:10.3892/ijo.2018.4484

The tumorigenic role of DSPP and its potential regulation of the unfolded protein response and ER stress in oral cancer cells

Authors:
- Ioannis Gkouveris
- Nikolaos G. Nikitakis
- Jaya Aseervatham
- Kalu U.E. Ogbureke
View Affiliations

Affiliations: Division of Diagnostic and Surgical Sciences, UCLA School of Dentistry, Los Angeles, CA 90095, USA, Department of Oral Medicine and Pathology, School of Dentistry, National and Kapodistrian University of Athens, Athens 11527, Greece, Department of Diagnostic and Biomedical Sciences, School of Dentistry, University of Texas Health Science Center at Houston, Houston, TX 77054, USA
Published online on: July 16, 2018 https://doi.org/10.3892/ijo.2018.4484
Pages: 1743-1751

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dentin sialophosphoprotein (DSPP) is upregulated in various human cancers, including head and neck squamous cell carcinoma. Cancer cells are commonly found under constant endoplasmic reticulum (ER) stress and exhibit increased levels of misfolded proteins, due to gene mutations and a stressful microenvironment. The present study examined the effects of DSPP silencing on the regulation of ER stress and the unfolded protein response (UPR) in oral cancer cells. A recently established stable DSPP short hairpin (sh)RNA-silenced OSC2 oral cancer cell line was used. The mRNA expression levels of ER stress-associated proteins, including 78 kDa glucose-regulated protein (GRP78), sarcoplasmic/endoplasmic reticulum calcium ATPase 2b (SERCA2b), inositol 1,4,5-trisphosphate receptor (IP3r), protein kinase R-like endoplasmic reticulum kinase (PERK), serine/threonine-protein kinase/endoribonuclease IRE1 (IRE1), activating transcription factor 6 (ATF6) and matrix metalloproteinase 20 (MMP20), were assessed by reverse transcription-quantitative polymerase chain reaction. The expression levels of apoptosis-related [B‑cell lymphoma 2 (Bcl2), Bcl2-associated X protein (Bax) and cytochrome c] and cell proliferation-related [proliferating cell nuclear antigen (PCNA)] proteins were analyzed by western blotting. Cell viability, apoptosis and migration were monitored by MTT assay, Annexin V-fluorescein isothiocyanate flow cytometry and wound-healing assay, respectively. In transiently transfected puromycin‑free OSC2 cells, DSPP silencing markedly downregulated the mRNA expression levels of major ER stress regulators, including GRP78, SERCA2b, PERK, IRE1 and ATF6, as well as MMP20. DSPP silencing also resulted in decreased cell viability and migration, and enhanced apoptosis. Furthermore, PCNA and Bcl2 levels were decreased, whereas Bax and cytochrome c protein levels were increased in DSPP-silenced OSC2 cells. Sustained puromycin treatment partially counteracted the effects of DSPP silencing on the mRNA expression levels of ER stress-related proteins and MMP20, and on the migratory capacity of OSC2 cells. However, following puromycin treatment of DSPP-silenced cells, cell viability was further reduced and apoptosis was enhanced. In conclusion, these data provide evidence to suggest that DSPP may be involved in ER stress mechanisms in oral squamous cell carcinoma, since its downregulation in OSC2 cells led to significant alterations in the levels of major ER stress-associated proteins, and subsequent collapse of the UPR system.

View Figures

View References

1	Bellahcène A, Castronovo V, Ogbureke KU, Fisher LW and Fedarko NS: Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): Multifunctional proteins in cancer. Nat Rev Cancer. 8:212–226. 2008. View Article : Google Scholar : PubMed/NCBI
2	Ogbureke KU and Fisher LW: Expression of SIBLINGs and their partner MMPs in salivary glands. J Dent Res. 83:664–670. 2004. View Article : Google Scholar : PubMed/NCBI
3	Ogbureke KU and Fisher LW: SIBLING expression patterns in duct epithelia reflect the degree of metabolic activity. J Histochem Cytochem. 55:403–409. 2007. View Article : Google Scholar : PubMed/NCBI
4	Koli K, Saxena G and Ogbureke KU: Expression of matrix metal-loproteinase (MMP)-20 and potential interaction with dentin sialophosphoprotein (DSPP) in human major salivary glands. J Histochem Cytochem. 63:524–533. 2015. View Article : Google Scholar : PubMed/NCBI
5	Yamakoshi Y, Hu JC, Iwata T, Kobayashi K, Fukae M and Simmer JP: Dentin sialophosphoprotein is processed by MMP-2 and MMP-20 in vitro and in vivo. J Biol Chem. 281:38235–38243. 2006. View Article : Google Scholar : PubMed/NCBI
6	Suzuki S, Sreenath T, Haruyama N, Honeycutt C, Terse A, Cho A, Kohler T, Müller R, Goldberg M and Kulkarni AB: Dentin sialoprotein and dentin phosphoprotein have distinct roles in dentin mineralization. Matrix Biol. 28:221–229. 2009. View Article : Google Scholar : PubMed/NCBI
7	Yang J, Kawasaki K, Lee M, Reid BM, Nunez SM, Choi M, Seymen F, Koruyucu M, Kasimoglu Y, Estrella-Yuson N, et al: The dentin phosphoprotein repeat region and inherited defects of dentin. Mol Genet Genomic Med. 4:28–38. 2015. View Article : Google Scholar
8	Alvares K, Stern PH and Veis A: Dentin phosphoprotein binds annexin 2 and is involved in calcium transport in rat kidney ureteric bud cells. J Biol Chem. 288:13036–13045. 2013. View Article : Google Scholar : PubMed/NCBI
9	Fisher LW, Jain A, Tayback M and Fedarko NS: Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers. Clin Cancer Res. 10:8501–8511. 2004. View Article : Google Scholar : PubMed/NCBI
10	Jain A, McKnight DA, Fisher LW, Humphreys EB, Mangold LA, Partin AW and Fedarko NS: Small integrin-binding proteins as serum markers for prostate cancer detection. Clin Cancer Res. 15:5199–5207. 2009. View Article : Google Scholar : PubMed/NCBI
11	Anunobi CC, Koli K, Saxena G, Banjo AA and Ogbureke KU: Expression of the SIBLINGs and their MMP partners in human benign and malignant prostate neoplasms. Oncotarget. 7:48038–48049. 2016. View Article : Google Scholar : PubMed/NCBI
12	Ogbureke KU, Nikitakis NG, Warburton G, Ord RA, Sauk JJ, Waller JL and Fisher LW: Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer. Oral Oncol. 43:920–932. 2007. View Article : Google Scholar : PubMed/NCBI
13	Saxena G, Koli K, de la Garza J and Ogbureke KU: Matrix metal-loproteinase 20-dentin sialophosphoprotein interaction in oral cancer. J Dent Res. 94:584–593. 2015. View Article : Google Scholar : PubMed/NCBI
14	Rao RV, Hermel E, Castro-Obregon S, del Rio G, Ellerby LM, Ellerby HM and Bredesen DE: Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem. 276:33869–33874. 2001. View Article : Google Scholar : PubMed/NCBI
15	Denmeade SR and Isaacs JT: The SERCA pump as a therapeutic target: Making a 'smart bomb' for prostate cancer. Cancer Biol Ther. 4:14–22. 2005. View Article : Google Scholar : PubMed/NCBI
16	Mekahli D, Bultynck G, Parys JB, De Smedt H and Missiaen L: Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb Perspect Biol. 3:32011. View Article : Google Scholar
17	Raturi A, Ortiz-Sandoval C and Simmen T: Redox dependence of endoplasmic reticulum (ER) Ca²⁺ signaling. Histol Histopathol. 29:543–552. 2014.
18	Giampietri C, Petrungaro S, Conti S, Facchiano A, Filippini A and Ziparo E: Cancer microenvironment and endoplasmic reticulum stress response. Mediators Inflamm. 2015:4172812015. View Article : Google Scholar : PubMed/NCBI
19	Wang M and Kaufman RJ: The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer. 14:581–597. 2014. View Article : Google Scholar : PubMed/NCBI
20	Lemus L and Goder V: Regulation of endoplasmic reticulum-associated protein degradation (ERAD) by ubiquitin. Cells. 3:824–847. 2014. View Article : Google Scholar : PubMed/NCBI
21	Yadav RK, Chae SW, Kim HR and Chae HJ: Endoplasmic reticulum stress and cancer. J Cancer Prev. 19:75–88. 2014. View Article : Google Scholar : PubMed/NCBI
22	Bertolotti A, Zhang Y, Hendershot LM, Harding HP and Ron D: Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol. 2:326–332. 2000. View Article : Google Scholar : PubMed/NCBI
23	Brown JM and Giaccia AJ: The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res. 58:1408–1416. 1998.PubMed/NCBI
24	He B: Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ. 13:393–403. 2006. View Article : Google Scholar : PubMed/NCBI
25	Martinon F: Targeting endoplasmic reticulum signaling pathways in cancer. Acta Oncol. 51:822–830. 2012. View Article : Google Scholar : PubMed/NCBI
26	Moenner M, Pluquet O, Bouchecareilh M and Chevet E: Integrated endoplasmic reticulum stress responses in cancer. Cancer Res. 67:10631–10634. 2007. View Article : Google Scholar : PubMed/NCBI
27	Wang J and Sevier CS: Formation and reversibility of BiP protein cysteine oxidation facilitate cell survival during and post oxidative stress. J Biol Chem. 291:7541–7557. 2016. View Article : Google Scholar : PubMed/NCBI
28	Koumenis C: ER stress, hypoxia tolerance and tumor progression. Curr Mol Med. 6:55–69. 2006. View Article : Google Scholar : PubMed/NCBI
29	Fu Y, Li J and Lee AS: GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 67:3734–3740. 2007. View Article : Google Scholar : PubMed/NCBI
30	Ye J, Kumanova M, Hart LS, Sloane K, Zhang H, De Panis DN, Bobrovnikova-Marjon E, Diehl JA, Ron D and Koumenis C: The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J. 29:2082–2096. 2010. View Article : Google Scholar : PubMed/NCBI
31	Thorpe JA and Schwarze SR: IRE1alpha controls cyclin A1 expression and promotes cell proliferation through XBP-1. Cell Stress Chaperones. 15:497–508. 2010. View Article : Google Scholar
32	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
33	Joshi R, Tawfik A, Edeh N, McCloud V, Looney S, Lewis J, Hsu S and Ogbureke KU: Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2. PLoS One. 5:e139742010. View Article : Google Scholar : PubMed/NCBI
34	Brunelle JK and Letai A: Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci. 122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
35	Heath-Engel HM, Wang B and Shore GC: Bcl2 at the endoplasmic reticulum protects against a Bax/Bak-independent paraptosis-like cell death pathway initiated via p20Bap31. Biochim Biophys Acta. 1823:335–347. 2012. View Article : Google Scholar
36	Wang X, Olberding KE, White C and Li C: Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosis. Cell Death Differ. 18:38–47. 2011. View Article : Google Scholar
37	Nutt LK, Pataer A, Pahler J, Fang B, Roth J, McConkey DJ and Swisher SG: Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca²⁺ stores. J Biol Chem. 277:9219–9225. 2002. View Article : Google Scholar
38	Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T and Korsmeyer SJ: BAX and BAK regulation of endoplasmic reticulum Ca²⁺: A control point for apoptosis. Science. 300:135–139. 2003. View Article : Google Scholar : PubMed/NCBI
39	Nagelkerke A, Bussink J, Sweep FC and Span PN: The unfolded protein response as a target for cancer therapy. Biochim Biophys Acta. 1846:277–284. 2014.PubMed/NCBI
40	Corazzari M, Gagliardi M, Fimia GM and Piacentini M: Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front Oncol. 7:782017. View Article : Google Scholar : PubMed/NCBI
41	Marchi S and Pinton P: Alterations of calcium homeostasis in cancer cells. Curr Opin Pharmacol. 29:1–6. 2016. View Article : Google Scholar : PubMed/NCBI
42	Lee E, Nichols P, Spicer D, Groshen S, Yu MC and Lee AS: GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Res. 66:7849–7853. 2006. View Article : Google Scholar : PubMed/NCBI
43	de Ridder G, Ray R, Misra UK and Pizzo SV: Modulation of the unfolded protein response by GRP78 in prostate cancer. Methods Enzymol. 489:245–257. 2011. View Article : Google Scholar : PubMed/NCBI
44	Dong D, Ni M, Li J, Xiong S, Ye W, Virrey JJ, Mao C, Ye R, Wang M, Pen L, et al: Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res. 68:498–505. 2008. View Article : Google Scholar : PubMed/NCBI
45	Fu Y, Wey S, Wang M, Ye R, Liao CP, Roy-Burman P and Lee AS: Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc Natl Acad Sci USA. 105:19444–19449. 2008. View Article : Google Scholar : PubMed/NCBI
46	Daneshmand S, Quek ML, Lin E, Lee C, Cote RJ, Hawes D, Cai J, Groshen S, Lieskovsky G, Skinner DG, et al: Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol. 38:1547–1552. 2007. View Article : Google Scholar : PubMed/NCBI
47	Ren P, Chen C, Yue J, Zhang J and Yu Z: High expression of glucose-regulated protein 78 (GRP78) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma. OncoTargets Ther. 10:617–625. 2017. View Article : Google Scholar
48	Zhang J, Jiang Y, Jia Z, Li Q, Gong W, Wang L, Wei D, Yao J, Fang S and Xie K: Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis. 23:401–410. 2006. View Article : Google Scholar : PubMed/NCBI
49	Kang J, Zhao G, Lin T, Tang S, Xu G, Hu S, Bi Q, Guo C, Sun L, Han S, et al: A peptide derived from phage display library exhibits anti-tumor activity by targeting GRP78 in gastric cancer multidrug resistance cells. Cancer Lett. 339:247–259. 2013. View Article : Google Scholar : PubMed/NCBI
50	Toyoshima C, Nomura H and Sugita Y: Crystal structures of Ca²⁺-ATPase in various physiological states. Ann N Y Acad Sci. 986:1–8. 2003. View Article : Google Scholar : PubMed/NCBI
51	Roti G, Carlton A, Ross KN, Markstein M, Pajcini K, Su AH, Perrimon N, Pear WS, Kung AL, Blacklow SC, et al: Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer. Cancer Cell. 23:390–405. 2013. View Article : Google Scholar : PubMed/NCBI
52	Casemore D and Xing C: SERCA as a target for cancer therapies. Integr Cancer Sci Ther. 2:100–103. 2015.
53	Dremina ES, Sharov VS, Kumar K, Zaidi A, Michaelis EK and Schöneich C: Anti-apoptotic protein Bcl-2 interacts with and destabilizes the sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase (SERCA). Biochem J. 383:361–370. 2004. View Article : Google Scholar : PubMed/NCBI
54	Axten JM, Medina JR, Feng Y, Shu A, Romeril SP, Grant SW, Li WH, Heerding DA, Minthorn E, Mencken T, et al: Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem. 55:7193–7207. 2012. View Article : Google Scholar : PubMed/NCBI
55	Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C, Cavener D and Diehl JA: PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene. 29:3881–3895. 2010. View Article : Google Scholar : PubMed/NCBI
56	Kanekura K, Ma X, Murphy JT, Zhu LJ, Diwan A and Urano F: IRE1 prevents endoplasmic reticulum membrane permeabili-zation and cell death under pathological conditions. Sci Signal. 8:ra622015. View Article : Google Scholar
57	Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, Mori K, Hada A, Arai M, Wakatsuki T, Matsubara O, et al: Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: A possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol. 38:605–614. 2003. View Article : Google Scholar : PubMed/NCBI
58	Dadey DY, Kapoor V, Khudanyan A, Urano F, Kim AH, Thotala D and Hallahan DE: The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma. Oncotarget. 7:2080–2092. 2016. View Article : Google Scholar :
59	Zhao G, Kang J, Jiao K, Xu G, Yang L, Tang S, Zhang H, Wang Y, Nie Y, Wu K, et al: High expression of GRP78 promotes invasion and metastases in patients with esophageal squamous cell carcinoma. Dig Dis Sci. 60:2690–2699. 2015. View Article : Google Scholar : PubMed/NCBI
60	Yuan XP, Dong M, Li X and Zhou JP: GRP78 promotes the invasion of pancreatic cancer cells by FAK and JNK. Mol Cell Biochem. 398:55–62. 2015. View Article : Google Scholar
61	Oguma T, Ono T, Kajiwara T, Sato M, Miyahira Y, Arino H, Yoshihara Y and Tadakuma T: CD4(+)CD8(+) thymocytes are induced to cell death by a small dose of puromycin via ER stress. Cell Immunol. 260:21–27. 2009. View Article : Google Scholar : PubMed/NCBI
62	Johnson GG, White MC, Wu JH, Vallejo M and Grimaldi M: The deadly connection between endoplasmic reticulum, Ca²⁺, protein synthesis, and the endoplasmic reticulum stress response in malignant glioma cells. Neuro-oncol. 16:1086–1099. 2014. View Article : Google Scholar
63	Hammadi M, Oulidi A, Gackière F, Katsogiannou M, Slomianny C, Roudbaraki M, Dewailly E, Delcourt P, Lepage G, Lotteau S, et al: Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: Involvement of GRP78. FASEB J. 27:1600–1609. 2013. View Article : Google Scholar : PubMed/NCBI
64	Michalak M, Milner RE, Burns K and Opas M: Calreticulin. Biochem J. 285:681–692. 1992. View Article : Google Scholar : PubMed/NCBI